EHA 2025 to spotlight breakthrough CML research and new ELN recommendations in Milan
As the European Hematology Association (EHA) gears up for its 30th Annual Congress, scheduled for June 12-15, 2025, in Milan, excitement is building within the Chronic Myeloid Leukaemia (CML) community. This year’s congress promises to be a pivotal platform for professionals engaged in CML biology, therapy, and patient care, showcasing not just the latest scientific advancements but also fostering invaluable interactions among clinicians, researchers, and industry leaders.
The congress aims to revolutionise professional learning in hematology, bringing together a diverse array of sessions that include plenary lectures, oral presentations, and poster exhibitions. Highlighting key aspects, the programme includes several CML-specific sessions addressing current challenges and breakthroughs. Notably, the Specialized Working Group Session on June 12 will delve into CML stem cells and disease modelling, previewing the anticipated 2025 European LeukemiaNet (ELN) recommendations—a crucial resource for clinicians working in this rapidly evolving field.
A significant component of the congress is the focus on novel treatment strategies. On June 14, an oral session will explore the intricacies of treatment response and resistance mechanisms related to BCR::ABL1 mutations. These discussions are particularly relevant as they shed light on early response predictions and biomarkers for treatment-free remission, which are of paramount importance for optimising patient outcomes. Alongside this, a robust selection of poster presentations is set to feature novel biomarkers and real-world experiences, underscoring the ongoing commitment to advancing understanding in CML.
Furthermore, the congress presents an opportunity for collaborative engagement through Satellite Symposia. Supported by industry leaders like Novartis, these sessions will precede the official programme, allowing for rich interaction and deeper dives into specific topics of interest.
An important aspect of EHA2025 is its emphasis on connectivity and collaboration. The congress's layout has been designed to facilitate networking opportunities amongst attendees. This year introduces an increased number of invited speaker sessions and second poster presentations, effectively accommodating the growing volume of abstract submissions. By ensuring a balanced distribution of programme content and fewer parallel sessions, EHA2025 is determined to maximise engagement and interaction among participants.
In addition, EHA members will benefit from exclusive features such as a dedicated members' lounge and a plenary Annual General Meeting, aimed at fostering community within the association. The commitment to enhancing the attendee experience is evident in the congress structure, which integrates a diverse range of hematology topics, from hemostasis and thrombosis to stem cell transplantation.
The format of the congress has also adapted to contemporary needs, with all sessions set to be live-streamed and available on-demand until mid-August. This flexibility is crucial, allowing those unable to attend in person to still partake in the wealth of knowledge shared at the event.
As anticipation builds for this landmark congress, organisers remain committed to providing a platform for innovation and discussion, ultimately driving progress in hematology. The CML community, with its diverse insights and collaborative spirit, stands to gain significantly from the focused discussions, enabling it to navigate the complex landscape of research and patient care effectively.
As June approaches, the CML Foundation is poised to offer detailed updates and additional insights into the congress, ensuring that all attendees are well-prepared to optimise their experience in Milan.